Literature DB >> 11246667

Uveitis as a cause of visual loss in arthritides and comparable conditions.

K Kotaniemi1, K Aho, A Kotaniemi.   

Abstract

OBJECTIVE: To examine the role of inflammatory rheumatic diseases and comparable conditions in the etiology of severe uveitis leading to visual impairment and blindness.
METHODS: A retrospective study based on the Finnish Register of Visual Impairment. At the end of 1996, the Finnish Register of Visual Impairment included 296 uveitis patients in whom uveitis was the main cause of visual impairment. The patient records were examined retrospectively to investigate the etiology of severe uveitis. Due to the incompleteness of data obtained of the patients blinded a long time ago, we included only 174 uveitis patients whose visual handicap (best corrected visual acuity in the better eye < 20/60 or severe visual field loss) was stated during 1980-1996.
RESULTS: A total of 174 uveitis patients were found, 72 male and 102 female. A diagnosed or presumed inflammatory rheumatic disease or comparable condition was found in 38/174 (22%) patients: juvenile rheumatoid arthritis in 14 (8%), spondyloarthropathy (ankylosing spondylitis or reactive arthritis) in 10 (6%), sarcoidosis in 5 (3%), seronegative rheumatoid arthritis in 4 (2%); Behçet's disease was diagnosed in 2 (1%), 1 patient had polymyositis, 1 polyarteritis nodosa, and 1 juvenile systemic lupus erythematosus. In addition to the above, 10 (6%) patients had chronic back pain and 5 (3%) patients various noninflammatory joint problems. Diverse other ophthalmologic or systemic disease was detected in 38 (22%) cases. Trauma or surgery caused uveitis in 9 (5%) patients. For 74/174 (43%) uveitis patients no specific associating condition could be shown. Legal blindness was documented in 65/174 (37%) patients, including 8 totally blind persons.
CONCLUSION: This study provides first data on the relative importance of inflammatory rheumatic diseases and comparable conditions in the etiology of severe uveitis leading to visual handicap and blindness.

Entities:  

Mesh:

Year:  2001        PMID: 11246667

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  [Vision-threatening complications in childhood uveitis].

Authors:  A Mingels; T Hudde; C Heinz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

2.  Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

Authors:  Norman Ilowite; Oscar Porras; Andreas Reiff; Sue Rudge; Marilynn Punaro; Alan Martin; Roger Allen; Terry Harville; Yu-Nien Sun; Terry Bevirt; Gary Aras; Brent Appleton
Journal:  Clin Rheumatol       Date:  2008-09-03       Impact factor: 2.980

Review 3.  Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  A Heiligenhaus; H Michels; C Schumacher; I Kopp; U Neudorf; T Niehues; H Baus; M Becker; B Bertram; G Dannecker; C Deuter; I Foeldvari; M Frosch; G Ganser; M Gaubitz; G Gerdes; G Horneff; A Illhardt; F Mackensen; K Minden; U Pleyer; M Schneider; N Wagner; M Zierhut
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

4.  Characterization and outcome of uveitis in 350 patients with spondyloarthropathies.

Authors:  Percival D Sampaio-Barros; Roseneide A Conde; Rubens Bonfiglioli; Manoel B Bértolo; Adil M Samara
Journal:  Rheumatol Int       Date:  2006-09-07       Impact factor: 2.631

5.  Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab.

Authors:  Sofia Lanz; Gerald Seidel; Andrea Skrabl-Baumgartner
Journal:  Pediatr Rheumatol Online J       Date:  2021-08-21       Impact factor: 3.054

6.  Uveitis and juvenile idiopathic arthritis: A cohort study.

Authors:  David BenEzra; Evelyne Cohen; Francine Behar-Cohen
Journal:  Clin Ophthalmol       Date:  2007-12

7.  Degree, duration, and causes of visual loss in uveitis.

Authors:  O M Durrani; N N Tehrani; J E Marr; P Moradi; P Stavrou; P I Murray
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

8.  Retrospective study on the effects of immunosuppressive therapy in uveitis associated with rheumatic diseases in Korea.

Authors:  Sang Yeob Lee; Won Tae Chung; Woo Jin Jung; Sung Won Lee
Journal:  Rheumatol Int       Date:  2011-12-24       Impact factor: 2.631

9.  Clinical and visual outcomes of patients with uveitis in the mid-Atlantic United States.

Authors:  Asima Bajwa; Chang Sup Lee; Jim Patrie; Wenjun Xin; Ashvini K Reddy
Journal:  Clin Ophthalmol       Date:  2015-09-08

10.  Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.

Authors:  Christoph Tappeiner; Sandra Schenck; Martina Niewerth; Arnd Heiligenhaus; Kirsten Minden; Jens Klotsche
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-01       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.